- $1.25bn
- $942.87m
- $216.98m
Annual income statement for Exzeo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 45.6 | 88.3 | 134 | 217 |
| Cost of Revenue | ||||
| Gross Profit | -26.1 | 17.3 | 53.2 | 131 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 83.4 | 85.8 | 95.9 | 111 |
| Operating Profit | -37.8 | 2.55 | 38 | 106 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -38.6 | 0.883 | 35.2 | 110 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -42 | 12.9 | 26.1 | 82.7 |
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | -59.3 | 21.5 | 45.3 | 82.7 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -68.4 | 12.1 | 35.2 | 82.7 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.564 | 0.039 | 0.176 | 1.03 |